Envestnet Asset Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34M | Sell |
42,385
-15,944
| -27% | -$504K | ﹤0.01% | 3083 |
|
|
2025
Q1 | $1.94M | Buy |
58,329
+4,503
| +8% | +$149K | ﹤0.01% | 2759 |
|
|
2024
Q4 | $1.85M | Buy |
53,826
+1,321
| +3% | +$45.5K | ﹤0.01% | 2739 |
|
|
2024
Q3 | $2.1M | Sell |
52,505
-8,892
| -14% | -$356K | ﹤0.01% | 2618 |
|
|
2024
Q2 | $1.85M | Buy |
61,397
+10,167
| +20% | +$307K | ﹤0.01% | 2647 |
|
|
2024
Q1 | $1.72M | Buy |
+51,230
| New | +$1.72M | ﹤0.01% | 2673 |
|
|
2023
Q3 | – | Sell |
-27,032
| Closed | -$951K | – | 4082 |
|
|
2023
Q2 | $951K | Sell |
27,032
-172,162
| -86% | -$6.06M | ﹤0.01% | 2784 |
|
|
2023
Q1 | $867K | Buy |
199,194
+173,036
| +662% | +$753K | ﹤0.01% | 2773 |
|
|
2022
Q4 | $1.44M | Buy |
26,158
+14,179
| +118% | +$781K | ﹤0.01% | 2387 |
|
|
2022
Q3 | $531K | Buy |
11,979
+5,448
| +83% | +$241K | ﹤0.01% | 2987 |
|
|
2022
Q2 | $319K | Buy |
+6,531
| New | +$319K | ﹤0.01% | 3320 |
|